Identification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1 (Q28283017)

1

0 references

M Rizzi

2

0 references

T J Grob

3

0 references

B Hügli

5

0 references

V A Reddy

6

0 references

A-C Andres

7

0 references

B E Torbett

8

0 references

A Tobler

9

0 references

M F Fey

Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines.

10

0 references

language of work or name

English

0 references

publication date

30 March 2006

0 references

published in

Oncogene

0 references

volume

25

0 references

page(s)

2030-9

0 references

issue

14

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209240

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209240

TP53 family members and human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209240

Requirement for p53 and p21 to sustain G2 arrest after DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209240

Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209240

Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209240

Recruitment of SMRT/N-CoR-mSin3A-HDAC-repressing complexes is not a general mechanism for BTB/POZ transcriptional repressors: the case of HIC-1 and gammaFBP-B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209240

Definition of a consensus binding site for p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209240

Identification of direct p73 target genes combining DNA microarray and chromatin immunoprecipitation analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209240

Methylation of the HIC-1 candidate tumor suppressor gene in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209240

Gene therapy of Fanconi anemia: preclinical efficacy using lentiviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209240

Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209240

Identification in the human candidate tumor suppressor gene HIC-1 of a new major alternative TATA-less promoter positively regulated by p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209240

Worms gang up on bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209240

DeltaNp73beta is active in transactivation and growth suppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209240

p53 upregulates death receptor 4 expression through an intronic p53 binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209240

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209240

Negative control of p53 by Sir2alpha promotes cell survival under stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209240

Construction of T-vectors, a rapid and general system for direct cloning of unmodified PCR products

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209240

Viral oncoproteins discriminate between p53 and the p53 homolog p73.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209240

p73: Friend or foe in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209240

PUMA, a novel proapoptotic gene, is induced by p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209240

Nutrient availability regulates SIRT1 through a forkhead-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209240

Expression of the Hypermethylated in Cancer gene (HIC-1) is associated with good outcome in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209240

Staf50 is a novel p53 target gene conferring reduced clonogenic growth of leukemic U-937 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209240

Identification of a second G-C-rich promoter conserved in the human, murine and rat tumor suppressor genes HIC1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209240

The tumor suppressor gene HIC1 (hypermethylated in cancer 1) is a sequence-specific transcriptional repressor: definition of its consensus binding sequence and analysis of its DNA binding and repressive properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209240

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) decoy receptor TRAIL-R3 is up-regulated by p53 in breast tumor cells through a mechanism involving an intronic p53-binding site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209240

p53-independent role of MDM2 in TGF-beta1 resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209240

Alternative splicing of the human cyclin D-binding Myb-like protein (hDMP1) yields a truncated protein isoform that alters macrophage differentiation patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209240

hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209240

p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209240

Analysis of p53 "latency" and "activation" by fluorescence correlation spectroscopy. Evidence for different modes of high affinity DNA binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209240

The tumor-suppressive functions of the human INK4A locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209240

p73 function is inhibited by tumor-derived p53 mutants in mammalian cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209240

inferred from DOI database lookup

7 January 2021

based on heuristic

The fundamental role of epigenetic events in cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209240

inferred from DOI database lookup

7 January 2021

based on heuristic

Groups of p53 target genes involved in specific p53 downstream effects cluster into different classes of DNA binding sites

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209240